Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 3
2004 2
2005 4
2006 5
2007 4
2008 3
2009 10
2010 7
2011 9
2012 3
2013 7
2014 14
2015 14
2016 9
2017 7
2018 12
2019 10
2020 10
2021 12
2022 16
Text availability
Article attribute
Article type
Publication date

Search Results

147 results
Results by year
Filters applied: . Clear all
Page 1
Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial.
Nichols AC, Theurer J, Prisman E, Read N, Berthelet E, Tran E, Fung K, de Almeida JR, Bayley A, Goldstein DP, Hier M, Sultanem K, Richardson K, Mlynarek A, Krishnan S, Le H, Yoo J, MacNeil SD, Winquist E, Hammond JA, Venkatesan V, Kuruvilla S, Warner A, Mitchell S, Chen J, Corsten M, Johnson-Obaseki S, Eapen L, Odell M, Parker C, Wehrli B, Kwan K, Palma DA. Nichols AC, et al. Among authors: hier m. Lancet Oncol. 2019 Oct;20(10):1349-1359. doi: 10.1016/S1470-2045(19)30410-3. Epub 2019 Aug 12. Lancet Oncol. 2019. PMID: 31416685 Clinical Trial.
Randomized Trial of Radiotherapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Long-Term Results of the ORATOR Trial.
Nichols AC, Theurer J, Prisman E, Read N, Berthelet E, Tran E, Fung K, de Almeida JR, Bayley A, Goldstein DP, Hier M, Sultanem K, Richardson K, Mlynarek A, Krishnan S, Le H, Yoo J, MacNeil SD, Winquist E, Hammond JA, Venkatesan V, Kuruvilla S, Warner A, Mitchell S, Chen J, Corsten M, Johnson-Obaseki S, Odell M, Parker C, Wehrli B, Kwan K, Palma DA. Nichols AC, et al. Among authors: hier m. J Clin Oncol. 2022 Mar 10;40(8):866-875. doi: 10.1200/JCO.21.01961. Epub 2022 Jan 7. J Clin Oncol. 2022. PMID: 34995124 Clinical Trial.
Assessment of Toxic Effects and Survival in Treatment Deescalation With Radiotherapy vs Transoral Surgery for HPV-Associated Oropharyngeal Squamous Cell Carcinoma: The ORATOR2 Phase 2 Randomized Clinical Trial.
Palma DA, Prisman E, Berthelet E, Tran E, Hamilton S, Wu J, Eskander A, Higgins K, Karam I, Poon I, Husain Z, Enepekides D, Hier M, Sultanem K, Richardson K, Mlynarek A, Johnson-Obaseki S, Odell M, Bayley A, Dowthwaite S, Jackson JE, Dzienis M, O'Neil J, Chandarana S, Banerjee R, Hart R, Chung J, Tenenholtz T, Krishnan S, Le H, Yoo J, Mendez A, Winquist E, Kuruvilla S, Stewart P, Warner A, Mitchell S, Chen J, Parker C, Wehrli B, Kwan K, Theurer J, Sathya J, Hammond JA, Read N, Venkatesan V, MacNeil SD, Fung K, Nichols AC. Palma DA, et al. Among authors: hier m. JAMA Oncol. 2022 Jun 1;8(6):1-7. doi: 10.1001/jamaoncol.2022.0615. JAMA Oncol. 2022. PMID: 35482348 Clinical Trial.
Advances and applications of oral cancer basic research.
da Silva SD, Ferlito A, Takes RP, Brakenhoff RH, Valentin MD, Woolgar JA, Bradford CR, Rodrigo JP, Rinaldo A, Hier MP, Kowalski LP. da Silva SD, et al. Among authors: hier mp. Oral Oncol. 2011 Sep;47(9):783-91. doi: 10.1016/j.oraloncology.2011.07.004. Epub 2011 Jul 29. Oral Oncol. 2011. PMID: 21802978 Review.
Preoperative Risk Index Among Patients Undergoing Thyroid or Parathyroid Surgery.
Mascarella MA, Milad D, Richardson K, Mlynarek A, Payne RJ, Forest VI, Hier M, Sadeghi N, Mayo N. Mascarella MA, et al. Among authors: hier m. JAMA Otolaryngol Head Neck Surg. 2020 Jan 1;146(1):7-12. doi: 10.1001/jamaoto.2019.2413. JAMA Otolaryngol Head Neck Surg. 2020. PMID: 31486838 Free PMC article.
Chitosan/PCL nanoparticles can improve anti-neoplastic activity of 5-fluorouracil in head and neck cancer through autophagy activation.
de Lima JM, Castellano LRC, Bonan PRF, de Medeiros ES, Hier M, Bijian K, Alaoui-Jamali MA, da Cruz Perez DE, da Silva SD. de Lima JM, et al. Among authors: hier m. Int J Biochem Cell Biol. 2021 May;134:105964. doi: 10.1016/j.biocel.2021.105964. Epub 2021 Mar 2. Int J Biochem Cell Biol. 2021. PMID: 33667680 Free article.
147 results